1,048
Views
56
CrossRef citations to date
0
Altmetric
Papers

Milk from cows of different β-casein genotypes as a source of β-casomorphin-7

, , , , &
Pages 426-430 | Published online: 14 Nov 2011

References

  • Arendonk JAM, Bovenhuis H. 2010. Association of bovine beta-casein protein variant with milk production and milk protein composition. Anim Genet. 42:212–218.
  • Birgisdóttir BE, Hill JP, Harris DP, Thorsdóttir I. 2002. Variation in consumption of cow milk proteins and lower rate of Type 1 diabetes in Iceland versus the other 4 Nordic countries. Diabetes Nutr Metab. 15:240–245.
  • Birgisdóttir BE, Hill JP, Thorsson AV, Thorsdóttir I. 2006. Lower consumption of cow milk protein A1 beta-casein at 2 years of age, rather than consumption among 11- to 14-year-old adolescents, may explain the lower rate of type 1 diabetes in Iceland than in Scandinavia. Ann Nutr Metab. 50:177–183.
  • Bitri L. 2004. Optimization study for the production of an opioid-like preparation from bovine casein by mild acidic hydrolysis. Int Dairy J. 14:535–539.
  • Caroli AM, Chessa S, Erhardt GJ. 2009. Milk protein polymorphism in cattle: effect on animal breeding and nutrition. J Dairy Sci. 9:5335–5352.
  • Cieślińska A, Kamiński S, Kostyra E, Sienkiewicz-Szłapka E. 2007. Beta-casomorphin 7 in raw and hydrolyzed milk derived from cows of alternative beta-casein genotypes. Milchwissenschaft. 62:125–127.
  • Clare DA, Swaisgood HE. 2000. Bioactive milk peptides: a perspective. J Dairy Sci. 83:1187–1195.
  • Considine T, Healy A, Kelly AL, McSweeney PLH. 1999. Proteolytic specificity of elastase on bovine β-casein. Food Chem. 66:463–470.
  • De Noni I. 2008. Release of beta-casomorphins 5 and 7 during simulated gastro-intestinal digestion of bovine beta-casein variants and milk-based infant formulas. Food Chem. 110:897–903.
  • Dixon WJ. 1951. Ratios involving extreme values. Ann Math Stat. 21:488–506.
  • EFSA Report. 2009. Review of the potential health impact of β-casomorphins and related peptides. EFSA Scientific Report. 231:1–107.
  • Elliott RB, Harris DP, Hill JP, Bibby NJ, Wasmuth HE. 1999. Type 1 (insulin-dependent) diabetes mellitus and cow milk: casein variant consumption. Diabetologia. 42:292–296.
  • Hartwig A, Teschemacher H, Lehmann W, Gauly M, Erhardt G. 1997. Influence of genetic polymorphisms in bovine milk on the occurrence of bioactive peptides. Int Dairy Federation. 9702:459–460.
  • Harwalkar VR, Elliott JA. 1971. Isolation of bitter and astringent fractions from Cheddar cheese. J. Dairy Sci. 54:8–11.
  • Heck JML, Schennink A, van Valenberg HJF, Bovenhuis H, Visker MHPW, van Arendonk JAM, van Hooijdonk ACM. 2009. Effects of milk protein variants on the protein composition of bovine milk. J Dairy Sci. 92:1192–1202.
  • Jakobsson I, Borulf S, Lindberg T, Benediktsson B. 1983. Partial hydrolysis of cow's milk proteins by human trypsin and elastases in vitro. J Pediatr Gastroenterol Nutr. 2:613–616.
  • Jinsmaa Y, Yoshikawa M. 1999. Enzymatic release of neocasomorphin and beta-casomorphin from bovine beta-casein. Peptides. 20:957–962.
  • Kamiński S, Ruść A, Cieślińska A. 2006. A note of A1 and A2 variants of bovine beta-casein locus in Polish Holstein bulls. J Anim Feed Sci. 15:195–198.
  • Kamiński S, Cieślińska A, Kostyra E. 2007. Polymorphism of bovine beta-casein and its potential effect on human health. J Appl Genet. 48:189–198.
  • Kessler HG. 1981. Food engineering and dairy technology. Freising: Verlag A. Kessler.
  • Kostyra E, Sienkiewicz-Szłapka E, Jarmołowska B, Krawczuk S, Kostyra H. 2004. Opioid peptides derived from milk proteins. Pol J Food Nutr Sci. 13 Suppl. 1: 25–35.
  • Kostyra H, Wociór A, Rudnicka B, Rydzewski M, Kostyra E. 2010. Influence of non-enzymatic glycosylation of sodium caseinate on the kinetics of its enzymatic hydrolysis. Milchwiseschaft. 65 3: 302–305.
  • Laugesen M, Elliott R. 2003. Ischaemic heart disease, Type 1 diabetes, and cow milk A1 beta-casein. NZ Med J. 116:1–19.
  • Lien S, Alestrom P, Hlungland H, Rogne S. 1992. Detection of multiple beta-casein (CASB) alleles by amplification created restriction sites (ACRS). Anim Genet. 23:333–338.
  • Meisel H. 2001. Bioactive peptides from milk proteins: a perspective for consumers and producers. Aus J Dairy Tech. 56:83–91.
  • McLachlan CNS. 2001. Beta-casein A1, ischaemic heart disease mortality, and other illnesses. Med Hypotheses. 56:262–272.
  • Meloun M, Hill M, Militky J, Kupka K. 2001. Analysis of large and small samples of biochemical and clinical data. Clin Chem Lab Med. 39:53–61.
  • Nilsen H, Olsen HG, Hayes B, Sehested E, Svendson M, Nome T, . 2009. Casein haplotypes and their associations with milk production traits in Norwegian Red cattle. Genet Sel Evol. 41:1–12.
  • Oleński K, Kamiński S, Szyda J, Cieślińska A. 2010. Polymorphism of the beta-casein gene and its associations with breeding value for production traits of Holstein–Fresian bulls. Livest Sci. 131:137–140.
  • Ott RL, Longnecker M. 2001. Pacific Grove. CA: Duxbury.
  • Park W. 2009. Bioactive components in milk and dairy products. Ames, IA: Wiley-Blackwell.
  • Phelan M, Aherne A, FitzGerald RJ, O'Brien NM. 2009. Casein-derived bioactive peptides: biological effects, industrial uses, safety aspects and regulatory status. Int Dairy J. 19:643–654.
  • Schmelzer CEH, Schöps R, Reynell L, Ulbrich-Hofmann R, Neubert RHH, Raith K. 2007. Peptic digestion of beta-casein. The course and fate of possible bioactive peptides. J Chromatogr A. 1166:108–115.
  • Sienkiewicz-Szłapka E, Jarmołowska B, Krawczuk S, Kostyra E, Kostyra H, Iwan M. 2009. Contents of agonistic and antagonistic opioid peptides in different cheese varieties. Int Dairy J. 19:258–263.
  • Silva SV, Malcata FX. 2005. Caseins as source of bioactive peptides. Int Dairy J. 15:1–15.
  • Sun Z, Cade R, Fregly MJ, Privette RM. 1999. ß-Casomorphin induces fos-like immunoreactivity in discrete brain regions relevant to Schizophrenia and Autism. Autism. 3:67–83.
  • Sun Z, Zhang Z, Wang X, Cade R, Elmir Z, Fregly M. 2003. Relation of beta-casomorphin to Apnea in sudden infant death syndrome. Peptides. 24:937–943.
  • Tailford KA, Berry CL, Thomas AC, Campbell JH. 2003. A casein variant in cow's milk is atherogenic. Atherosclerosis. 170:13–19.
  • Thorsdóttir IBE, Birgisdóttir IM, Johannsdóttir DP, Harris J, Hill L, Steingrimsdóttir L, Thorsson A. 2000. Different beta-casein fractions in Icelandic versus Scandinavian cow's milk may influence diabetogenicity of cow's milk in infancy and explain low rate of insulin-dependent diabetes mellitus in Iceland. Pediatrics. 106:719–724.
  • Visker MHP, Dibbits BW, Kinders SM, van Valenberg HJF, Arendonk JAM, Bovenhuis H. 2010. Association of bovine beta-casein protein variant with milk production and milk protein composition. Anim Genet. 42:212–218.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.